Cognitive phenotyping of amyloid precursor protein transgenic J20 mice

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 392-397

  Karl, Tim ^a,b,c   Bhatia, Surabhi ^a,c,d   Cheng, David ^a,c   Kim, Woojin Scott ^a,c   Garner, Brett ^d  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Alzheimer's disease; APP; J20; Learning and memory; Transgenic mouse model

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; COGNITION; CONTROLLED STUDY; FEAR; FOOTSHOCK; LATENT PERIOD; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REFERENCE MEMORY; REWARD; SHORT TERM MEMORY; STIMULUS RESPONSE; TASK PERFORMANCE; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; FEAR; FOOD PREFERENCES; HUMANS; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; MUTATION; PHENOTYPE; RECOGNITION (PSYCHOLOGY); SPATIAL BEHAVIOR;

EID: 84856216952     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.12.021     Document Type: Article

References (33)

1. Rosenberg R.N. The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture. Neurology 2000, 54:2045-2054.
2. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9:532-544.
3. Gotz J., Streffer J.R., David D., Schild A., Hoerndli F., Pennanen L., et al. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry 2004, 9:664-683.
4. Kobayashi D.T., Chen K.S. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 2005, 4:173-196.
5. Gerlai R. Behavioral tests of hippocampal function: simple paradigms complex problems. Behav Brain Res 2001, 125:269-277.
6. Iivonen H., Nurminen L., Harri M., Tanila H., Puolivali J. Hypothermia in mice tested in Morris water maze. Behav Brain Res 2003, 141:207-213.
7. Llano Lopez L., Hauser J., Feldon J., Gargiulo P.A., Yee B.K. Evaluating spatial memory function in mice: a within-subjects comparison between the water maze test and its adaptation to dry land. Behav Brain Res 2010, 209:85-92.
8. Mizunoya W., Oyaizu S., Hirayama A., Fushiki T. Effects of physical fatigue in mice on learning performance in a water maze. Biosci Biotechnol Biochem 2004, 68:827-834.
9. Wolfer D.P., Stagljar-Bozicevic M., Errington M.L., Lipp H.P. Spatial memory and learning in transgenic mice: fact or artifact?. News Physiol Sci 1998, 13:118-123.
10. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995, 373:523-527.
11. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000, 20:4050-4058.
12. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992, 1:345-347.
13. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991, 254:97-99.
14. Galvan V., Zhang J., Gorostiza O.F., Banwait S., Huang W., Ataie M., et al. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav Brain Res 2008, 191:246-255.
15. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 2006, 103:7130-7135.
16. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q., Raber J., et al. Neuronal depletion of calciumdependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 2003, 100:9572-9577.
17. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
18. Sanchez-Mejia R.O., Newman J.W., Toh S., Yu G.Q., Zhou Y., Halabisky B., et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 2008, 11:1311-1318.
19. Chesworth R., Downey L., Logge W., Killcross S., Karl T. Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav Brain Res 2011, 226:218-223.
20. Duffy L., Cappas E., Lai D., Boucher A.A., Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 2010, 170:800-807.
21. Hughes R.N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev 2004, 28:497-505.
22. Pang T.Y., Stam N.C., Nithianantharajah J., Howard M.L., Hannan A.J. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006, 141:569-584.
23. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
24. Holmes A., Wrenn C.C., Harris A.P., Thayer K.E., Crawley J.N. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 2002, 1:55-69.
25. McNally G.P., Westbrook R.F. Predicting danger: the nature, consequences, and neural mechanisms of predictive fear learning. Learn Mem 2006, 13:245-253.
26. Radulovic J., Tronson N.C. Molecular specificity of multiple hippocampal processes governing fear extinction. Rev Neurosci 2010, 21:1-17.
27. Stiedl O., Spiess J. Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav Neurosci 1997, 111:703-711.
28. Cisse M., Halabisky B., Harris J., Devidze N., Dubal D.B., Sun B., et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 2011, 469:47-52.
29. Cisse M., Sanchez P.E., Kim D.H., Ho K., Yu G.Q., Mucke L. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 2011, 31:10427-10431.
30. Harris J.A., Devidze N., Halabisky B., Lo I., Thwin M.T., Yu G.Q., et al. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 2010, 30:372-381.
31. Deipolyi A.R., Fang S., Palop J.J., Yu G.Q., Wang X., Mucke L. Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol Aging 2008, 29:253-266.
32. Pillay N.S., Kellaway L.A., Kotwal G.J. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Behav Brain Res 2008, 192:173-177.
33. Takao K., Tanda K., Nakamura K., Kasahara J., Nakao K., Katsuki M., et al. Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice. PLoS ONE 2010, 5:e9460.